Status:

COMPLETED

Clarithromycin for the Treatment of Hypersomnia

Lead Sponsor:

Lynn Marie Trotti

Conditions:

Hypersomnia

Idiopathic Hypersomnia

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The term 'hypersomnia' describes a group of symptoms that includes severe daytime sleepiness and sleeping long periods of time (more than 10 hours per night). Sometimes, hypersomnia is caused by a pro...

Detailed Description

Central hypersomnias are characterized by severe excessive daytime sleepiness despite long sleep periods (\>10 hours/night) and the absence of nocturnal sleep pathology. They preferentially affect you...

Eligibility Criteria

Inclusion

  • Hypersomnia (meeting clinical criteria for Idiopathic hypersomnia with or without long sleep time, narcolepsy lacking cataplexy, or symptomatic hypersomnia not meeting ICSD criteria)
  • evidence for GABA-related abnormality, as demonstrated by in-house, in vitro assay
  • age \> 18
  • high performance liquid chromatography/liquid chromatography tandem mass spectrometry verification of the absence of exogenous benzodiazepines

Exclusion

  • Contraindications to use of clarithromycin (pregnancy, severe renal impairment, history of QT prolongation, hypomagnesemia, hypokalemia, bradycardia, history of myocardial infarction or cardiomyopathy, myasthenia gravis, age \> 70)
  • Current use of cisapride, pimozide, astemizole, terfenadine, colchicines, and ergotamine or dihydroergotamine
  • Current use of benzodiazepines or benzodiazepine-receptor agonists
  • moderate or severe sleep apnea (RDI \> 15/hr), severe periodic limb movement disorder (PLMI \> 30/hr)
  • diagnosis of narcolepsy with cataplexy, as determined by cerebrospinal hypocretin levels
  • metabolic disorders such as anemia, severe iron deficiency, B12 deficiency, or hypothyroidism that may explain symptoms of hypersomnia

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2012

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT01146600

Start Date

July 1 2010

End Date

September 1 2012

Last Update

November 6 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Emory Sleep Center

Atlanta, Georgia, United States, 30329

Clarithromycin for the Treatment of Hypersomnia | DecenTrialz